S&P Global Revenue Increased 9% In The Third Quarter With Growth Across All Four Divisions

S&P Global (NYSE: SPGI) today reported third quarter 2020 results with revenue of $1,846 million, an increase of 9% compared to the same period last year. Net income decreased 26% to $455 million and diluted earnings per share decreased 25% to $1.88 primarily due to the debt tender premium and fees associated with the recent senior notes tender offer.

Adjusted net income increased 14% to $689 million and adjusted diluted earnings per share increased 16% to $2.85 primarily due to revenue growth, productivity programs, and reduced expenses across the Company from COVID-19 related management actions. The largest adjustment in the third quarter of 2020 was associated with the debt tender premium and fees. In addition, there were adjustments for deal-related amortization and Kensho retention-related expenses. The third quarter of 2019 included adjustments for the gains on the divestitures of SPIAS and RigData as well as deal-related amortization and Kensho retention-related expenses.

“S&P Global has a collection of strong and resilient businesses that continued to perform well in the current environment. The demand for our ratings, benchmarks, research, data, and analytics is greater than ever during uncertain and volatile markets,” said Douglas L. Peterson, President and Chief Executive Officer of S&P Global. “Two years ago, we established a number of growth initiatives. It is very encouraging to see so many of these investments result in new products that we have launched this year. This is particularly true with our ESG investments and the traction that our new ESG products are gaining in the marketplace.”

Profit Margin: The Company’s operating profit margin decreased 160 basis points to 51.1% primarily due to the prior period benefiting from the dispositions of the SPIAS and RigData businesses. The adjusted operating profit margin increased 100 basis points to 52.9% primarily due to revenue growth, productivity programs, and reduced expenses across the Company from COVID-19 related management actions.

Return of Capital: During the quarter, the Company returned $172 million to shareholders. This included $161 million in dividends and $11 million in share repurchases which represented the conclusion of the share repurchase program initiated in February of this year. During the first nine months of 2020, the Company has returned $1.64 billion to shareholders consisting of $1.16 billion in share repurchases and $484 million in dividends.
more detail at: http://investor.spglobal.com/file/Index?KeyFile=405728290

Related Posts

Grainger Releases 2023 Environmental, Social and Governance (ESG) Report

Grainger announced the release of its 2023 Environmental, Social & Governance (ESG) Report on www.GraingerESG.com. The report, which covers the fiscal year that ended Dec. 31, 2022, highlights how Grainger's purpose-driven culture directly supports its ESG initiatives. The report also emphasizes Grainger's focus on four key priorities: Customer Sustainability Solutions, Supplier Diversity, Energy and Emissions, and Diversity, Equity and Inclusion (DEI).

AAP Preliminary Report Puts Religion Book Sales up 7.8% in 2023 (publishersweekly.com)

Sales of religious books at companies that report results to the Association of American Publishers’ StatShot program rose 7.8% last year over 2022, hitting $819.7 million. All formats expect e-books had an increase. The biggest gain was in trade paperback where sales increased 11.1%. Hardcover sales rose 6.7% and accounted for 60.1% of segment sales last year, roughly even compared to 2022. On the digital side, sales of digital audiobooks rose 8.5%, but e-book sales fell 3.3%.

AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction

AmerisourceBergen Corporation and Walgreens Boots Alliance, Inc. announced strategic agreements under which AmerisourceBergen will acquire the majority of Walgreens Boots Alliance’s Alliance Healthcare businesses for approximately $6.5 billion, comprised of $6.275 billion in cash and 2 million shares of AmerisourceBergen common stock. AmerisourceBergen’s acquisition of Alliance Healthcare will provide even stronger support for pharmacies and pharmacists across the globe and integrated solutions for pharmaceutical manufacturers. Walgreens Boots Alliance will be able to increase its focus on expanding its core retail pharmacy businesses, bringing even greater healthcare offerings to patients and customers and further accelerating its progress on its clear set of strategic priorities.
Back To Top
×Close search
Search